Valrubicin |
(2S-cis)-2-[[4-(3-Trifluoroacetylamino-2,3,6-trideoxy-alpha-L-lyxo-hexapyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5-12-trihydroxy-7-methoxy-6,11-dioxo-2-naphtacenyl]-2-oxoethyl ester |
(CAS 56124-62-0) |
 |
Description: |
Valrubicin (AD-32) is a chemotherapy drug used to treat bladder cancer.
Target: Others
Valrubicin is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder. |
Product No. |
KT20024 |
Product Name |
Valrubicin |
Synonyms |
Valstar; Valtaxin; AD-32 |
Formal Name |
(2S-cis)-2-[[4-(3-Trifluoroacetylamino-2,3,6-trideoxy-alpha-L-lyxo-hexapyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5-12-trihydroxy-7-methoxy-6,11-dioxo-2-naphtacenyl]-2-oxoethyl ester |
CAS Number |
56124-62-0 |
Molecular Formula |
C34H36F3NO13 |
Formula Weight |
723.64 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
1 year |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500. |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
Doxorubicin
Panobinostat
Veliparib
Olaparib
Epiruicin
Idarubicin hydrochloride
Amonafide
Amrubicin hydrochloride
Amsacrine hydrochloride
|
|